Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus
|Published in||Journal of Rheumatology. 1993, vol. 20, no. 7, p. 1143-1151|
|Abstract||OBJECTIVE: The pituitary hormone, prolactin, accelerates systemic lupus erythematosus in NZB/NZW F1 (B/W) mice. Our study evaluated disease activity in B/W females experiencing the physiologic hyperprolactinemia of mating, pregnancy, suckling, and pseudopregnancy. METHODS: Nonsuckling postpartum, suckling and pseudopregnant mice were compared to virgin females. Serum prolactin, anti-DNA antibodies (anti-DNA), gp70-anti-gp70 immune complexes, IgM, IgG, albuminuria, and renal function were monitored serially. RESULTS: Females that whelped 2 litters had apparent stimulation of anti-DNA; those that suckled their young had similar premature appearance of anti-DNA as well as delayed, but marked, hypergammaglobulinemia. Pseudopregnant mice, which characteristically secrete repeated surges of prolactin, had significant acceleration of multiple variables of disease activity. CONCLUSIONS: Pregnancy, parturition and suckling did not immediately accelerate lupus in B/W dams, and longevity was not affected in females that had borne litters. Pseudopregnancy was the most effective stimulator of variables of autoimmunity.|
|Keywords||Albuminuria/physiopathology — Animals — Animals, Suckling/ physiology — Antibodies, Antinuclear/analysis — Antigen-Antibody Complex/analysis — Autoimmunity — Blood Urea Nitrogen — Disease Models, Animal — Female — Hypergammaglobulinemia/blood/physiopathology — Immunoglobulin G/analysis — Immunoglobulin M/analysis — Kidney/physiology — Labor, Obstetric/ physiology — Longevity — Lupus Erythematosus, Systemic/immunology/ physiopathology — Male — Mice — Mice, Inbred NZB — Mice, Inbred Strains — Pregnancy — Prolactin/blood/physiology — Pseudopregnancy/ physiopathology — Severity of Illness Index|
This document has no fulltext available yet, but you can contact its author by using the form below.